Duco Launches the First Agentic Operations Platform for Financial Services
27.5.2026 09:20:00 CEST | Business Wire | Press release
Duco, today launched the first agentic Operations platform for financial services. Built on the engine that already processes 20 billion transactions every month for more than 200 clients, including seven of the top 20 banks and ten of the top 20 asset managers, the platform brings together everything firms need to run post-trade Operations alongside autonomous agents, safely and at scale.
The launch establishes a breakthrough the industry has been waiting for.
A tool surface, purpose-built for agents. Duco has unbundled its platform into a new alternative agent layer that reconfigures its platform into hundreds of discrete capabilities servicing post trade. Model Context Protocol (MCP) gives capabilities covering reconciliation, data preparation, data access, audit trails, exception management, document creation and more. For the first time, agents have a verified, deterministic toolset built specifically for post-trade. Agents do not replace matching, rules or audit; they use them. Provable accuracy is the reason agents can be trusted in Operations.
Duco also announces the pacesetters cohort. Duco has convened a group of the most ambitious post-trade Operations leaders in financial services. Pacesetters have first access to capabilities as they ship, direct input into product development, and a head-start on the operational model of the future. 10 firms are already live with Duco agents in production today. Our next wave of Pacesetters opens today.
Why post-trade, and why now
Post-trade Operations sit at the intersection of three pressures that agentic AI is uniquely positioned to address: shrinking settlement windows, growing transaction volumes, and a generational shift in who does the work and how. Manual handling is increasingly hard to justify. Legacy systems are a dead-end for AI. The firms that move first will set the standard for everyone who follows.
"For more than a decade, our clients have trusted Duco to reconcile the most complex data in capital markets. They are now telling us that agents will run a meaningful share of post-trade Operations within three years. Duco is assembling the most powerful set of tools and context ever built for Operations to enable this," said Christian Nentwich, CEO and co-founder of Duco.
"What we are launching today is not another AI feature," Nentwich continued. "It is the operating system for post-trade in the agentic era. The Pacesetters are defining what good looks like for everyone else and we will share what they learn so the whole industry can move faster."
Pacesetters are already reporting results that would have been impossible six months ago. In early deployments, building a new reconciliation process on the Duco Platform has dropped from two days to four hours with roughly twenty minutes of agent runtime and the rest spent on human review. Auto-built workflows from raw inputs, continuous optimisation of existing processes, and accelerated exception investigation are moving from roadmap to daily operating reality.
Availability and how to engage
The Duco agentic Operations platform is available today. Applications for the next Pacesetters wave are open to qualifying financial services firms visit du.co or contact your Duco representative. A demonstration of Agentic Workspace and the tool surface is available at du.co/agentic-workspace.
About Duco
Duco is empowering financial services to transform the work undertaken in Operations by automating manual work and elevating humans from task workers to decision makers.
We do this with a combination of proprietary technique, innovative cloud computing, artificial intelligence technology, and deep subject matter expertise.
Our agentic Operations platform gives firms the ability to unlock full end-to-end reconciliation, data trust and automation of their data, regardless of source, format or structure.
By partnering with the industry's leading firms, we are helping to rethink operating models, increase efficiency, strengthen governance and regulatory compliance, reduce risk, streamline processes and build the workforce of the future.
More than 10,000 users across 30+ countries process billions of data records every week using the platform.
Duco is headquartered in London, with offices in New York, Wroclaw, Antwerp and Singapore. Customers include global banks, investment managers, exchanges and insurance firms, such as CIBC Mellon, ING and Man Group. For more information go to www.du.co
View source version on businesswire.com: https://www.businesswire.com/news/home/20260527267379/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Brenus Pharma Announces FDA Acceptance of IND Application for STC-1010 (BreAK-CRC001) in MSS Metastatic Colorectal Cancer (mCRC)27.5.2026 08:49:00 CEST | Press release
STC-1010 is a first-in-class allogeneic in vivo immunotherapy for which the FDA has authorized clinical evaluation in the U.S. under the BreAK-CRC001 study. This strategic milestone enables the company to execute a global clinical strategy following European regulatory approvals (ANSM, AFMPS), first patients dosed with preliminary results and good tolerability observed in early Phase Ia. First data are expected to be presented during ESMO annual congress 2026. Brenus Pharma, a clinical stage biotechnology company developing novel in vivo immunotherapies for solid tumors, announced that the U.S. Food and Drug Administration (FDA) has accept the company's Investigational New Drug (IND) application for its first drug candidate, STC-1010, in microsatellite stable (MSS) metastatic colorectal cancer (mCRC). STC-1010 is designed to address a critical unmet need worldwide. Approximately 95% of mCRC patients have MSS tumors, which demonstrate minimal response to standard immunotherapies. The FD
Tide Crosses 2 Million Members Worldwide - Big Step Forward in Mission to Support and Grow Small Businesses27.5.2026 08:00:00 CEST | Press release
Continuing to grow in the UK and internationally, with India seeing especially strong member growth in the last 12 months In the UK, Tide has 15% market share and has helped small businesses access over £1.75bn in credit Rapid roll out of products; from admin, accounting and tax tools; subscription options; payment solutions; government registrations; bill payments and credit Tide, the UK’s leading business management platform, today announces it has crossed 2 million members globally, with India in particular seeing strong growth. More than 1.1 million small businesses joined Tide in India since the company launched there in December 2022. This makes India Tide’s fastest-growing market by member acquisition. The UK is Tide’s home market, with 900,000 SMEs, 15% market share, and the majority of the company’s revenue. Tide’s steadily expanding its presence in Europe, with Germany and France, where the platform is gaining strong traction, thanks to millions of small businesses turning to
Alfasigma presents first data on filgotinib from the Phase 3 OLINGUITO trial in axial spondyloarthritis at EULAR 202627.5.2026 08:00:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific and investor media only.In the OLINGUITO Phase 3 study in radiographic (r) and non-radiographic (nr) axial spondyloarthritis (axSpA) a significantly greater proportion of patients achieved the prespecified primary endpoint of ASAS40 with filgotinib compared with placebo at week 16.The improvements in signs and symptoms of axSpA with filgotinib, an oral, once-daily JAK1 preferential inhibitor, were observed as early as week 1 and maintained over 52 weeks of treatment.In the r-axSpA and nr-axSpA filgotinib groups, of those achieving a response in the prespecified primary endpoint of ASAS40 at week 16, 84.6% and 78.0% maintained their responses to week 52, respectively.In OLINGUITO no new safety signals were observedfor filgotinib over 52 weeks, and the safety profile was consistent with the known overall safety profile.Primary results from the Phase 3 OLINGUITO tria
Royal London Asset Management Expands Relationship with SS&C to Service New Australian Funds27.5.2026 00:00:00 CEST | Press release
SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced that Royal London Asset Management, a leading U.K. fund management company, has extended its relationship with SS&C. SS&C Global Investor & Distribution Solutions will provide fund administration and unit registry services for its new range of Australian active funds, including: Royal London Global Equity Diversified Fund Royal London Global Equity Enhanced Fund Royal London Global Equity Select Fund Royal London Short Duration Global High Yield Bond Fund RLAM is part of Royal London, the U.K.’s largest mutual life, pensions and investment company. SS&C services approximately £72bn in assets under management across its U.K. fund range. Equity Trustees will serve as the Responsible Entity for RLAM’s new funds, which have launched with around AUD $1 billion in AUM. The unit trusts are structured as feeder funds, providing investors with indirect exposure to RLAM’s range of Dublin-domiciled Undertakings for Collective Investm
SLB Announces Date for Second-Quarter 2026 Results Conference Call26.5.2026 19:00:00 CEST | Press release
SLB (NYSE: SLB) will hold a conference call on July 24, 2026, to discuss the results for the second quarter ending June 30, 2026. The conference call is scheduled to begin at 9:30 a.m. U.S. Eastern time and a press release regarding the results will be issued at 7:00 a.m. U.S. Eastern time. To access the conference call, listeners should contact the Conference Call Operator at +1 (800) 715-9871 within North America or +1 (646) 307-1963 outside of North America approximately 10 minutes prior to the start of the call and the access code is 3440360. A webcast of the conference call will be broadcast simultaneously at https://events.q4inc.com/attendee/157027565 on a listen-only basis. Listeners should log in 15 minutes prior to the start of the call to test their browsers and register for the webcast. Following the end of the conference call, a replay will be available at www.slb.com/irwebcast until July 31, 2026, and can be accessed by dialing +1 (800) 770-2030 within North America or +1
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom